<DOC>
	<DOC>NCT00742066</DOC>
	<brief_summary>In this study we hypothesize that blocking the angiotensin II AT1-receptor improves the insulin-induced microvascular dilatation. Objectives: 1. Does blockade of the angiotensin II AT1-receptor improve the insulin-induced microvascular effects in hypertensive patients. 2. Does blockade of the angiotensin II AT1-receptor impair the insulin-induced microvascular effects in normotensive control subjects?</brief_summary>
	<brief_title>Role of AT1-receptor Blockers in Insulin-induced Vasodilation.</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<mesh_term>Felodipine</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<criteria>hypertensive subjects: 1. 1860 years 2. Caucasian 3. untreated hypertension &gt;140/90mmHg. normotensive subjects: 1. 1860 years 2. Caucasian 3. Blood pressure &lt;140/90 mmHg. 1. Obesity (BMI&gt;27kg/m2) 2. Cardiovascular disease (stroke, coronary artery disease, peripheral vascular disease, heart failure) 3. Impaired glucose tolerance or diabetes mellitus according to the criteria of the ADA 4. Smoking 5. Alcohol use &gt;4U/day 6. Use of medication (antihypertensive drugs, lipid lowering drugs, corticosteroids, NNSAIDs) 7. Pregnancy 8. Wearing contact lenses</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Microcirculation</keyword>
	<keyword>Angiotensin II receptor blocker</keyword>
</DOC>